Rebekka Hovd defends her PhD

MicroPath PhD student Rebekka Rolfsnes Hovd defended her PhD on 22nd January 2026. Her PhD was entitled "Antibiotic adjuvants to reverse B-lactam resistance: Mechanism of action and resistance development of chelator-based metallo-B-lactamase inhibitors". Rebekka did an industrial PhD financed through the Research Council of Norway, while she was employed in the biotech company AdjuTec Pharma. The adjudication committee for the defense was: Professor Linus Sandegren, Department of Medical Biochemistry and Microbiology, Uppsala University; Professor Marit Otterlei, Department of Clinical and Molecular Medicine, Norwegian University of Science and Technology and Professor Liv Mathiesen, Section for Pharmacology and Pharmaceutical Biosciences, Department of Pharmacy, University of Oslo

Follow Rebekka for her future career in science: https://www.linkedin.com/in/rebekka-rolfsnes-hovd-714416253/